Defiance Daily Target 2x Long MSTR ETF (NASDAQ:MSTX)
Old Forum Content for MSTX
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- traderbren: #FYI - UPSIDE MOVERS: $EBIO (+30.27%) Has acquired Viventia Bio for 4 million in shares $CLVS ( 6.95%) Reportedly a takeover target by Eli Lilly(LLY) , upgraded at Credit Suisse to outperform from neutral, PT raised to $41 from $19 $ADBE ( 5.35%) Q3 earnings beat expectations, revenue in-line, guides Q4 EPS above street view $PPHM ( 4.99%) Sunrise trial showing positive results for treatment of patients with non-squamous non-small cell lung cancer $FDX ( 3.66%) Reported better-than-expected fiscal Q1 EPS and sales DOWNSIDE MOVERS: $MSTX (-81.95%) Phase 3 sickle-cell treatment fails to meet primary endpoints $CDNA (-7.67%) Announced public offering of common stock $KMX (-6.33%) Reported below consensus revenue as average sale price declines
- TRICIA: $MSTX -↑ 8% pm ... ... watch this one ....some think this is great news. EF (ejection fraction .. a measure of the force of the left ventricle pumping blood into your system) 20% improved with no effect on Heart rate and BP? maybe a Cardiologist's dream. Baker Brothers own a sizable chunk .. http://finance.yahoo.com/news/mast-announces-results-nonclinical-study-130000010.html
- chuckd: $MSTX - @jnag698 - long $MSTX and up a bit on my position. Can you say more about your sense of where this ticker is going to move on this news. LONG. up a small amount on my position. Thnks for any info.
- chuckd: $MSTX @jnag698 - thanks for the reply!
- chuckd: $MSTX - anyone following this ticker? any news?
- chuckd: $MSTX - a small cap biotech - trading from .55 to .67 today. Is anyone following this ticker? quite a move today.
- chuckd: $MSTX - @tricia. Hope you are feeling better soon. I wonder if you are familiar with this ticker, or could point me to some helpful background?
- chuckd: $MSTX - I would appreciate it if anyone with knowledgeable biotech savvy would weigh in on this ticker? Thanks.
- Tricia: $MSTX Canaccord like Mast Therapeutics on sickle cell potential. Canaccord starts Mast Therapeutics at Buy. Analyst Ritu Baral likes MST-188's (Orphan designation in Europe) chances in sickle cell, and says EPIC "is well designed enough to to support FDA and EMA approval by itself if ... successful." Expect read-out in 2016. Baral sees U.S. market launch in 2017 and peak sales of around $400M by 2023. Price target is $3, which, even counting this morning's double-digit gains, translates into a 477% upside.
| Stock Price | $145.84 |
| Change | -15.11% |
| Volume | 8,695,940 |
Mast Therapeutics Inc is a biopharmaceutical company develops novel therapies for serious or life-threatening diseases with significant unmet needs.
Request Video of MSTXAlready a member? Sign in here.
Past Month
Leading Peers
-
$11.19 147.11%
-
$171.80 135.76%
-
$5.62 103.82%
Past Month
Lagging Peers
-
$6.93 -95.45%
-
$8.73 -64.20%
-
$6.28 -60.24%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!